Characteristics of young illicit drug injectors who use North America's first medically supervised safer injecting facility
暂无分享,去创建一个
J. Montaner | E. Wood | T. Kerr | M. Tyndall | Kathy Li | W. Small | Cari Miller | J. Stoltz | E. Wood | Jo-Anne M. Stoltz
[1] J. Frankish,et al. Binge Drug Use Independently Predicts HIV Seroconversion Among Injection Drug Users: Implications for Public Health Strategies , 2006, Substance use & misuse.
[2] A. Moss,et al. Heroin overdose among young injection drug users in San Francisco. , 2005, Drug and alcohol dependence.
[3] J. Montaner,et al. Do supervised injecting facilities attract higher-risk injection drug users? , 2005, American journal of preventive medicine.
[4] S. Galea,et al. A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000–2003 , 2005, Journal of Urban Health.
[5] J. Montaner,et al. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users , 2004, Harm reduction journal.
[6] J. Burns,et al. Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances , 2004, The Medical journal of Australia.
[7] J. Boivin,et al. Mortality in a cohort of street youth in Montreal. , 2004, JAMA.
[8] J. Frankish,et al. The Future Face of Coinfection: Prevalence and Incidence of HIV and Hepatitis C Virus Coinfection Among Young Injection Drug Users , 2004, Journal of acquired immune deficiency syndromes.
[9] J. Montaner,et al. Rationale for evaluating North America's first medically supervised safer-injecting facility. , 2004, The Lancet. Infectious diseases.
[10] E. Regidor,et al. Unusually strong association between education and mortality in young adults in a community with a high rate of injection-drug users. , 2003, European journal of public health.
[11] M. Schechter,et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic , 2003, AIDS.
[12] R. Hogg,et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[13] R. Hogg,et al. The Potential Public Health and Community Impacts of Safer Injecting Facilities: Evidence From a Cohort of Injection Drug Users , 2003, Journal of acquired immune deficiency syndromes.
[14] J. Montaner,et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users , 2002, Hepatology.
[15] M. Schechter,et al. Females Experiencing Sexual and Drug Vulnerabilities Are at Elevated Risk for HIV Infection Among Youth Who Use Injection Drugs , 2002, Journal of acquired immune deficiency syndromes.
[16] R. Hogg,et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic , 2002 .
[17] M. Schechter,et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[18] M. Schechter,et al. HIV incidence and associated risk factors among young injection drug users. , 2002, AIDS.
[19] A. Kilbourne,et al. Psychiatric Symptoms, Health Services, and HIV Risk Factors Among Homeless Women , 2002, Journal of health care for the poor and underserved.
[20] M. Schechter,et al. Hospital utilization and costs in a cohort of injection drug users. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[21] J. Montaner,et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[22] D. Culhane,et al. The Co-Occurrence of AIDS and Homelessness : Results from the Integration of Administrative Data for AIDS Surveillance and Public Shelter Utilization in Philadelphia , 2015 .
[23] A. Moss,et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco , 2001, Hepatology.
[24] J. Rehm,et al. Social costs of untreated opioid dependence , 2000, Journal of Urban Health.
[25] Julio S. G. Montaner,et al. Antiretroviral medication use among injection drug users: two potential futures , 2000, AIDS.
[26] M. O’Shaughnessy,et al. Toronto street youth and HIV/AIDS: prevalence, demographics, and risks. , 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[27] Wouter Jong,et al. The professional acceptance of drug use: a closer look at drug consumption rooms in the Netherlands, Germany and Switzerland , 1999 .
[28] Julio S. G. Montaner,et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.
[29] P. Bourgois,et al. Social misery and the sanctions of substance abuse : Confronting HIV risk among homeless heroin addicts in San Francisco , 1997 .
[30] I. English,et al. HIV/AIDS among Youth , 2008 .
[31] D. Vlahov,et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. , 2001, American journal of public health.